IDH1 and central nervous system cancer: The occurrence of p.R132H mutation of IDH1 is an early mechanism of gliomagenesis of lower grade gliomas and secondary glioblastoma, and Turcan et al. demonstrated that MEOX2 expression negatively correlated with IDH1 mutation.